adenosine monophosphate has been researched along with sphingosine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clark, RB; Johnson, JA | 1 |
| Bell, RM; Cohen, MV; Downey, JM; White, J; Yang, XM; Yellon, DM | 1 |
2 other study(ies) available for adenosine monophosphate and sphingosine
| Article | Year |
|---|---|
Multiple non-specific effects of sphingosine on adenylate cyclase and cyclic AMP accumulation in S49 lymphoma cells preclude its use as a specific inhibitor of protein kinase C.
Topics: Adenosine Monophosphate; Adenylyl Cyclases; Animals; Cell Membrane; Colforsin; Cyclic AMP; Epinephrine; Lymphoma; Protein Kinase C; Serum Albumin, Bovine; Sphingosine; Tumor Cells, Cultured | 1990 |
Cangrelor-Mediated Cardioprotection Requires Platelets and Sphingosine Phosphorylation.
Topics: Adenosine Monophosphate; Animals; Blood Platelets; Cardiotonic Agents; Heart; Ischemic Postconditioning; Ischemic Preconditioning, Myocardial; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Phosphorylation; Phosphotransferases (Alcohol Group Acceptor); Protective Agents; Purinergic P2Y Receptor Antagonists; Rats; Rats, Sprague-Dawley; Sphingosine | 2016 |